Heterogeneous nuclear ribonucleoprotein E3 (hnRNP E3) is a pivotal RNA-binding protein intricately involved in various facets of RNA metabolism, playing fundamental roles in gene expression regulation within the cell. As a member of the hnRNP family, hnRNP E3 exerts its functions primarily through interactions with RNA molecules, influencing processes such as pre-mRNA splicing, mRNA stability, translation, and transport. Its diverse activities stem from its ability to recognize specific RNA sequences and structures, thereby modulating RNA processing events critical for the production of functional transcripts. Additionally, hnRNP E3 participates in the formation of dynamic ribonucleoprotein complexes by interacting with other proteins, contributing to the intricate regulatory networks governing gene expression.
Activation of hnRNP E3 involves a complex interplay of regulatory mechanisms that modulate its RNA-binding activity and subcellular localization. One key mechanism of activation entails post-translational modifications, such as phosphorylation, acetylation, and methylation, which can alter hnRNP E3's conformation, stability, and interactions with RNA and other proteins. These modifications often occur in response to cellular signaling cues, thereby linking hnRNP E3's activity to various physiological stimuli and environmental changes. Additionally, the availability of hnRNP E3's binding partners, including other RNA-binding proteins and splicing factors, can influence its activation state by facilitating the formation of functional ribonucleoprotein complexes. Furthermore, changes in cellular compartmentalization, mediated by nuclear-cytoplasmic shuttling signals or interactions with membrane-bound organelles, can dynamically regulate hnRNP E3's access to its RNA targets, further modulating its activation status. Overall, the intricate regulatory mechanisms governing hnRNP E3 activation underscore its central role in orchestrating gene expression programs in response to cellular cues and environmental stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, it alters gene expression patterns, potentially influencing hnRNP E3 activity indirectly by modifying RNA processing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, affects chromatin remodeling and gene expression, possibly impacting hnRNP E3 function in RNA processing. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor, alters DNA methylation, potentially affecting hnRNP E3's role in gene regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, it can modify chromatin structure, potentially influencing hnRNP E3 activity indirectly. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor, it influences gene expression and could indirectly impact hnRNP E3 function. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomains, potentially affecting transcription regulation and indirectly influencing hnRNP E3. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could indirectly affect hnRNP E3 by altering protein degradation pathways, impacting RNA processing factors. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, could indirectly influence hnRNP E3 through alterations in cellular protein homeostasis. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Inhibits DNA methyltransferases, potentially impacting gene expression and indirectly influencing hnRNP E3. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects various signaling pathways and gene expression, potentially having an indirect impact on hnRNP E3 function. | ||||||